Spyre Therapeutics, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 98.96 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports